LTC4

Ltc4 is a lipid of Fatty Acyls (FA) class. Ltc4 is associated with abnormalities such as Asthma, Eosinophilia, Pulmonary Eosinophilia, Pneumonia and Cardiovascular Diseases. The involved functions are known as Signal, Gene Expression, Stimulus, Signal Transduction and Metabolic Inhibition. Ltc4 often locates in Plasma membrane, Cytoplasm, Back, Cytoplasmic and Tissue membrane. The associated genes with LTC4 are STIM1 gene, ABCC2 gene, CD9 gene, Mutant Proteins and Amino Acids, Aromatic. The related lipids are glycolithocholate.

Cross Reference

Introduction

To understand associated biological information of LTC4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with LTC4?

LTC4 is suspected in Pneumonia, Asthma, Pulmonary Eosinophilia, Eosinophilia, Cardiovascular Diseases, Disintegration and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with LTC4

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Acute-Phase Reaction D000210 12 associated lipids
Airway Obstruction D000402 13 associated lipids
Anaphylaxis D000707 35 associated lipids
Angina Pectoris D000787 27 associated lipids
Arthritis D001168 41 associated lipids
Asbestosis D001195 8 associated lipids
Asthma D001249 52 associated lipids
Asthma, Exercise-Induced D001250 10 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Cholestasis, Extrahepatic D001651 7 associated lipids
Body Weight D001835 333 associated lipids
Burns D002056 34 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cestode Infections D002590 3 associated lipids
Colitis D003092 69 associated lipids
Common Bile Duct Diseases D003137 3 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Per page 10 20 50 100 | Total 75

PubChem Associated disorders and diseases

What pathways are associated with LTC4

Lipid pathways are not clear in current pathway databases. We organized associated pathways with LTC4 through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with LTC4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with LTC4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with LTC4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with LTC4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with LTC4?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with LTC4

Download all related citations
Per page 10 20 50 100 | Total 1173
Authors Title Published Journal PubMed Link
Venkatachalam TK et al. Substituted heterocyclic thiourea compounds as a new class of anti-allergic agents inhibiting IgE/Fc epsilon RI receptor mediated mast cell leukotriene release. 2003 Bioorg. Med. Chem. pmid:12614897
Plath KE et al. Calcineurin antagonists differentially affect mediator secretion, p38 mitogen-activated protein kinase and extracellular signal-regulated kinases from immunologically activated human basophils. 2003 Clin. Exp. Allergy pmid:12614449
Kwak WJ et al. Papyriflavonol A from Broussonetia papyrifera inhibits the passive cutaneous anaphylaxis reaction and has a secretory phospholipase A2-inhibitory activity. 2003 Biol. Pharm. Bull. pmid:12612436
Mizutani N [Studies on the experimental allergic rhinitis induced by Japanese cedar pollen--role of cysteinyl leukotrienes in nasal allergic symptoms]. 2003 Yakugaku Zasshi pmid:12607939
Wang DY et al. The upper and lower airway responses to nasal challenge with house-dust mite Blomia tropicalis. 2003 Allergy pmid:12580812
Serio KJ et al. Lipopolysaccharide down-regulates the leukotriene C4 synthase gene in the monocyte-like cell line, THP-1. 2003 J. Immunol. pmid:12574384
Venkatachalam TK et al. Inhibition of mast cell leukotriene release by thiourea derivatives. 2003 Bioorg. Med. Chem. Lett. pmid:12565956
Bellou A et al. Constitutive nitric oxide synthase inhibition combined with histamine and serotonin receptor blockade improves the initial ovalbumin-induced arterial hypotension but decreases the survival time in brown norway rats anaphylactic shock. 2003 Shock pmid:12558148
Mastalerz L et al. Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist. 2002 Eur. J. Clin. Invest. pmid:12534456
Liu P et al. Cysteinyl leukotriene-dependent [Ca2+]i responses to angiotensin II in cardiomyocytes. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12531730
Tedla N et al. Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12529506
Chen ZS et al. Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10). 2003 Mol. Pharmacol. pmid:12527806
Ma L et al. Identification and characterization of the canine multidrug resistance-associated protein. 2002 Mol. Cancer Ther. pmid:12516967
Nagase T et al. A potent inhibitor of cytosolic phospholipase A2, arachidonyl trifluoromethyl ketone, attenuates LPS-induced lung injury in mice. 2003 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12505870
Yang SH et al. The stimulatory effects of nasal discharge from patients with perennial allergic rhinitis on normal human neutrophils are normalized after treatment with a new mixed formula of Chinese herbs. 2002 Int. Immunopharmacol. pmid:12469937
Walch L et al. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle. 2002 Br. J. Pharmacol. pmid:12466244
Wiklund CU et al. Interactions of volatile anesthetics with cholinergic, tachykinin, and leukotriene mechanisms in isolated Guinea pig bronchial smooth muscle. 2002 Anesth. Analg. pmid:12456432
Oliveira SH et al. Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis. 2002 Blood pmid:12453875
Ren XQ et al. A positively charged amino acid proximal to the C-terminus of TM17 of MRP1 is indispensable for GSH-dependent binding of substrates and for transport of LTC4. 2002 Biochemistry pmid:12450376
Evans JF Cysteinyl leukotriene receptors. 2002 Prostaglandins Other Lipid Mediat. pmid:12432945
Uemura M et al. Cysteinyl leukotrienes in the bile of patients with obstructive jaundice. 2002 J. Gastroenterol. pmid:12424566
Belinsky MG et al. Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). 2002 Cancer Res. pmid:12414644
Tabas LB and Dantzig AH A high-throughput assay for measurement of multidrug resistance protein-mediated transport of leukotriene C4 into membrane vesicles. 2002 Anal. Biochem. pmid:12413474
Lee SH and Altenberg GA Transport of leukotriene C4 by a cysteine-less multidrug resistance protein 1 (MRP1). 2003 Biochem. J. pmid:12398766
Hashimoto K et al. Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome. 2002 Hepatology pmid:12395335
Koike K et al. Multiple membrane-associated tryptophan residues contribute to the transport activity and substrate specificity of the human multidrug resistance protein, MRP1. 2002 J. Biol. Chem. pmid:12388549
Vargaftig BB and Singer M Leukotrienes, IL-13, and chemokines cooperate to induce BHR and mucus in allergic mouse lungs. 2003 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12388339
Keitel V et al. A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2). 2003 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12388192
Oleschuk CJ et al. Substitution of Trp1242 of TM17 alters substrate specificity of human multidrug resistance protein 3. 2003 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12388190
Liu S et al. Neuroimmune interactions in guinea pig stomach and small intestine. 2003 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12388180
Tsuruoka S et al. Functional analysis of ABCA8, a new drug transporter. 2002 Biochem. Biophys. Res. Commun. pmid:12379217
ten Hove T et al. Differential susceptibility of multidrug resistance protein-1 deficient mice to DSS and TNBS-induced colitis. 2002 Dig. Dis. Sci. pmid:12353855
Nobata K et al. Alpha(1L)-, but not alpha(1H)-, adrenoceptor antagonist prevents allergic bronchoconstriction in guinea pigs in vivo. 2002 Eur. J. Pharmacol. pmid:12323390
Suzuki Y et al. Silver activates calcium signals in rat basophilic leukemia-2H3 mast cells by a mechanism that differs from the Fc epsilon RI-activated response. 2002 J. Immunol. pmid:12244196
Bandeira-Melo C et al. Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion. 2002 J. Exp. Med. pmid:12235216
Yang Y et al. Structural and functional consequences of mutating cysteine residues in the amino terminus of human multidrug resistance-associated protein 1. 2002 J. Biol. Chem. pmid:12235150
Hagmann W et al. Reconstitution of transport-active multidrug resistance protein 2 (MRP2; ABCC2) in proteoliposomes. 2002 Biol. Chem. pmid:12222674
Gebhardt T et al. Cultured human intestinal mast cells express functional IL-3 receptors and respond to IL-3 by enhancing growth and IgE receptor-dependent mediator release. 2002 Eur. J. Immunol. pmid:12209644
Haimeur A et al. Charged amino acids in the sixth transmembrane helix of multidrug resistance protein 1 (MRP1/ABCC1) are critical determinants of transport activity. 2002 J. Biol. Chem. pmid:12186871
Arango P and Kountakis SE Presence of cysteinyl leukotrienes in asthmatic patients with chronic sinusitis. 2002 Laryngoscope pmid:12169896
Ohashi M et al. Effects of phalloidin on the biliary excretion of cholephilic compounds in rats. 2002 Pharmacology pmid:12169763
Hashizume K and Black KL Increased endothelial vesicular transport correlates with increased blood-tumor barrier permeability induced by bradykinin and leukotriene C4. 2002 J. Neuropathol. Exp. Neurol. pmid:12152787
Gibbs BF et al. Regulation of mediator secretion in human basophils by p38 mitogen-activated protein kinase: phosphorylation is sensitive to the effects of phosphatidylinositol 3-kinase inhibitors and calcium mobilization. 2002 J. Leukoc. Biol. pmid:12149431
Thomas LL et al. Immobilized lactoferrin is a stimulus for eosinophil activation. 2002 J. Immunol. pmid:12097406
Bandeira-Melo C et al. Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils. 2002 J. Allergy Clin. Immunol. pmid:12063527
Fernández SB et al. Role of the N-terminal transmembrane region of the multidrug resistance protein MRP2 in routing to the apical membrane in MDCKII cells. 2002 J. Biol. Chem. pmid:12060660
Oliveira SH et al. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8. 2002 J. Leukoc. Biol. pmid:12050188
Conrad S et al. A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance. 2002 Pharmacogenetics pmid:12042670
Mao Q et al. GSH-dependent photolabeling of multidrug resistance protein MRP1 (ABCC1) by [125I]LY475776. Evidence of a major binding site in the COOH-proximal membrane spanning domain. 2002 J. Biol. Chem. pmid:12034727
Christmas P et al. Membrane localization and topology of leukotriene C4 synthase. 2002 J. Biol. Chem. pmid:12023288
de las Heras B et al. Effects of six diterpenes on macrophage eicosanoid biosynthesis. 2001 Life Sci. pmid:12005260
Sawatzky DA et al. Eosinophil adhesion to cholinergic nerves via ICAM-1 and VCAM-1 and associated eosinophil degranulation. 2002 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12003784
Kingham PJ et al. Adhesion-dependent interactions between eosinophils and cholinergic nerves. 2002 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12003778
Ravasi S et al. Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma. 2002 Biochem. Pharmacol. pmid:11996896
Kolaczkowska E et al. Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. 2002 Inflammation pmid:11989789
Bandeira-Melo C et al. IL-16 promotes leukotriene C(4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling. 2002 J. Immunol. pmid:11971026
Norman BH et al. Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1). 2002 Bioorg. Med. Chem. Lett. pmid:11958985
Ahamed J and Ali H Distinct roles of receptor phosphorylation, G protein usage, and mitogen-activated protein kinase activation on platelet activating factor-induced leukotriene C(4) generation and chemokine production. 2002 J. Biol. Chem. pmid:11934880
Maekawa A et al. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses. 2002 J. Biol. Chem. pmid:11932261
Zhang DW et al. Determinants of the substrate specificity of multidrug resistance protein 1: role of amino acid residues with hydrogen bonding potential in predicted transmembrane helix 17. 2002 J. Biol. Chem. pmid:11925441
Neu IS et al. Leukotrienes in patients with clinically active multiple sclerosis. 2002 Acta Neurol. Scand. pmid:11903112
Guo A et al. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT). 2002 Drug Metab. Dispos. pmid:11901101
Jedlitschky G and Keppler D Transport of leukotriene C4 and structurally related conjugates. 2002 Vitam. Horm. pmid:11898391
Iliás A et al. Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). 2002 J. Biol. Chem. pmid:11880368
Küsters S et al. Effects of antihistamines on leukotriene and cytokine release from dispersed nasal polyp cells. 2002 Arzneimittelforschung pmid:11878205
Bäck M et al. Modulation of vascular tone and reactivity by nitric oxide in porcine pulmonary arteries and veins. 2002 Acta Physiol. Scand. pmid:11851592
Sakata K and Bäck M Receptor preferences of cysteinyl-leukotrienes in the guinea pig lung parenchyma. 2002 Eur. J. Pharmacol. pmid:11834255
Shon YH et al. Effect of Astragali radix extract on lipopolysaccharide-induced inflammation in human amnion. 2002 Biol. Pharm. Bull. pmid:11824562
Bermejo BP et al. Sesquiterpenes from Jasonia glutinosa: in vitro anti-inflammatory activity. 2002 Biol. Pharm. Bull. pmid:11824534
Fukuishi N et al. Antiallergic effect of ardisiaquinone A, a potent 5-lipoxygenase inhibitor. 2001 Phytomedicine pmid:11824521
Chrubasik S et al. Harpagophytum extracts. 2002 Clin. Pharmacol. Ther. pmid:11823764
Suzuki R and Freed AN Heparin inhibits hyperventilation-induced late-phase hyperreactivity in dogs. 2002 Am. J. Respir. Crit. Care Med. pmid:11779726
Wang J et al. [The effects of resuscitation with hypertonic saline solution on the postburn pulmonary injury in scalded dogs]. 2001 Zhonghua Shao Shang Za Zhi pmid:11774813
Malaviya R and Uckun FM Role of STAT6 in IgE receptor/FcepsilonRI-mediated late phase allergic responses of mast cells. 2002 J. Immunol. pmid:11751988
Miller DS et al. Xenobiotic efflux pumps in isolated fish brain capillaries. 2002 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:11742838
Miura K et al. Localizing a control region in the pathway to leukotriene C(4) secretion following stimulation of human basophils with anti-IgE antibody. 2001 J. Immunol. pmid:11739523
Fernández MA et al. New insights into the mechanism of action of the anti-inflammatory triterpene lupeol. 2001 J. Pharm. Pharmacol. pmid:11732756
Martin V et al. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors. 2001 Biochem. Pharmacol. pmid:11705452
Bölke E et al. Inflammatory response during abdominal and thyroid surgery: a prospective clinical trial on mediator release. 2001 Shock pmid:11699069
Miura K et al. Piceatannol is an effective inhibitor of IgE-mediated secretion from human basophils but is neither selective for this receptor nor acts on syk kinase at concentrations where mediator release inhibition occurs. 2001 Clin. Exp. Allergy pmid:11696049
Terlouw SA et al. Role of multidrug resistance protein 2 (MRP2) in glutathione-bimane efflux from Caco-2 and rat renal proximal tubule cells. 2001 Br. J. Pharmacol. pmid:11682439
Ohno N et al. Prognostic significance of multidrug resistance protein in adult T-cell leukemia. 2001 Clin. Cancer Res. pmid:11595704
Duffy SM et al. Resting and activation-dependent ion channels in human mast cells. 2001 J. Immunol. pmid:11591748
Hui Y et al. The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization. 2001 J. Biol. Chem. pmid:11591709
Schroeder JT et al. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. 2001 Clin. Exp. Allergy pmid:11591186
Kamohara M et al. Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells. 2001 Biochem. Biophys. Res. Commun. pmid:11587533
Thomas LL et al. Peptide-based analysis of amino acid sequences important to the biological activity of eosinophil granule major basic protein. 2001 Immunol. Lett. pmid:11578692
Sano A et al. Regulation of eosinophil function by phosphatidylinositol-specific PLC and cytosolic PLA(2). 2001 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:11557588
Malaviya R and Uckun FM Leflunomide metabolite analogue alpha-cyano-beta-hydroxy-beta-methyl-N-[3-(trifluoromethyl)phenyl]propenamide inhibits IgE/FcepsilonRI receptor-mediated mast cell leukotriene release and allergic asthma in mice. 2001 Sep-Oct Am J Ther pmid:11550070
Tornhamre S et al. Inhibitory effects of helenalin and related compounds on 5-lipoxygenase and leukotriene C(4) synthase in human blood cells. 2001 Biochem. Pharmacol. pmid:11543725
Wehner J and Neuber K Staphylococcus aureus enterotoxins induce histamine and leukotriene release in patients with atopic eczema. 2001 Br. J. Dermatol. pmid:11531797
Abad MJ et al. Effects of furocoumarins from Cachrys trifida on some macrophage functions. 2001 J. Pharm. Pharmacol. pmid:11518028
Bölke E et al. Changes of gut barrier function during anesthesia and cardiac surgery. 2001 Angiology pmid:11515987
Qian YM et al. Characterization of binding of leukotriene C4 by human multidrug resistance protein 1: evidence of differential interactions with NH2- and COOH-proximal halves of the protein. 2001 J. Biol. Chem. pmid:11507101
Aoki M et al. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor. 2001 J. Pharmacol. Exp. Ther. pmid:11504812
Ito K et al. Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity. 2001 J. Biol. Chem. pmid:11500505
Miura K et al. Differences in functional consequences and signal transduction induced by IL-3, IL-5, and nerve growth factor in human basophils. 2001 J. Immunol. pmid:11490016
Bäck M et al. An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea. 2001 Br. J. Pharmacol. pmid:11487525
Strenzke N et al. Mercuric chloride enhances immunoglobulin E-dependent mediator release from human basophils. 2001 Toxicol. Appl. Pharmacol. pmid:11485386
Falcón-Pérez JM et al. Domain interactions in the yeast ATP binding cassette transporter Ycf1p: intragenic suppressor analysis of mutations in the nucleotide binding domains. 2001 J. Bacteriol. pmid:11466279